BLASST-1: Combining nivolumab, gemcitabine and cisplatin for the neoadjuvant tre...
Dr Shilpa Gupta - Case Comprehensive Cancer Center, Cleveland, USA
14 Feb 2020
Management of patients with advanced seminoma
Prof Peter Albers - Düsseldorf University, Düsseldorf, Germany
14 Feb 2020
CHHip: Conventional versus hypofractionated high-dose intensity modulated radiot...
Prof David Dearnaley - Institute of Cancer Research, London, UK
14 Feb 2020
Latest advances in mHSPC from ASCO GU 2020
Dr Eleni Efstathiou and Prof Axel Merseburger
14 Feb 2020
ASCO GU 2020: Updates in renal cancer
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
14 Feb 2020
Beyond p-values: When does clinical impact outweigh statistical significance?
Prof Matthew Sydes - University College London, London, UK
14 Feb 2020
Prostate-specific membrane antigen PET: Who should undergo advanced imaging?
Dr Jérémie Calais - David Geffen School of Medicine UCLA, Los Angeles, USA
14 Feb 2020
Latest in prostate: Updates from TITAN, CARD and the era of personalised medicin...
Prof Karim Fizazi, Dr Elena Castro and Prof Axel Merseburger
14 Feb 2020
Echo-guided biopsy versus digital-guided biopsy of the prostate
Dr Mbassi Achille Aurèlei - Yaounde Central Hospital, Yaounde, Cameroon
7 Feb 2020
The risk of prostate cancer amongst African and Caribbean men in the UK
Prof Frank Chinegwundoh - Barts Health NHS Trust, London, UK
7 Feb 2020
Surgical innovations in Sub-Saharan Africa
Prof Frank Chinegwundoh - Barts Health NHS Trust, London, UK
7 Feb 2020
Where have we got to with cancer treatment?
Prof Alexander Eggermont - Princess Máxima Center for Pediatric Oncology, Utrech...
27 Jan 2020
